Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2004
11/30/2004US6825019 Polypeptides having β-1,3-galactosyl transferase activity
11/30/2004US6825018 Sorbitol dehydrogenase, gene encoding the same and use thereof
11/30/2004US6825013 Isolation of biosynthesis genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O, and their use
11/30/2004US6825012 Nucleotide sequences for use as tools in genetic engoneering
11/30/2004US6825011 For cloning/dna libraries; concatemers; polymerase chain reaction (pcr); fusion proteins
11/30/2004US6825008 Expressed ligand—vascular intercellular signalling molecule
11/30/2004US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids
11/30/2004US6825006 Preparing an insect-resistant plant, genetic engineered insecticides, crystal protein from culturing the cells, encoding endotoxins having insecticidal activity
11/30/2004US6825004 Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof
11/30/2004US6825002 Generation of carotenoid compounds in culture; obtain genetically engineered microorganism, culture under conditions which generate carotenoids, recover products
11/30/2004US6824996 Generating vitamin c in microorganism; obtain micoorganism, incubate in presence of carbon source, recover vitamin c
11/30/2004US6824989 Screening/detection of disease for diagnosis/research; genetic engineering; electrophoresis
11/30/2004US6824983 Method for the mutagenesis of nucleotide sequences in plants algae or fungi
11/30/2004US6824976 Method for selective inactivation of viral replication
11/30/2004US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
11/30/2004US6824773 TWEAK receptor
11/30/2004US6824772 Bacillus licheniformis biofungicide
11/30/2004CA2267072C Reconstituted human anti-hm1.24 antibody
11/30/2004CA2072350C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
11/26/2004CA2447737A1 Cellophane agar medium, and method for observing a microbe
11/25/2004WO2004101826A2 Methods to identify compounds that modulate the autoinducer-2 dependent quorum sensing system in vibrio harveyi
11/25/2004WO2004101812A2 Chromogenic plating medium for the rapid presumptive identification of bacillus anthracis, bacillus cereus, and bacillus thuringiensis
11/25/2004WO2004101803A2 Process for producing anticancer agent ll-d45042
11/25/2004WO2004101796A1 Improved transformant and process for producing polyester using the same
11/25/2004WO2004101768A2 Recombinant comamonas testosreroni 5-mgam-4d amids and carboxylic acid production
11/25/2004WO2004101757A2 Production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004WO2004101753A2 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004WO2004101746A2 Production of carotenoids in microorganisms
11/25/2004WO2004101732A1 Method for preparation of a suspension of micro-organisms
11/25/2004WO2004101616A1 LIVER X RECEPTOR α SPLICING MUTANT PROTEIN, GENE THEREOF AND UTILIZATION OF THE SAME
11/25/2004WO2004101513A2 Preparation of (e)- and (z)-2-methyl-2-butenoic acids
11/25/2004WO2004101449A2 Method of degrading tbp using a photosynthetic bacterial strain
11/25/2004WO2004087890A3 A method of enhancing levels of polyunsaturated fatty acids in thraustochytrid protists
11/25/2004WO2004065423A3 Recognition molecules for the treatment and detection of tumours
11/25/2004WO2004031363A3 Room temperature stable competent cells
11/25/2004WO2004018635A3 Myxococcus xanthus bacteriophage mx9 transformation and integration system
11/25/2004WO2004018624A3 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes
11/25/2004WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004WO2003050260A3 Streptavidin expressed gene fusions and methods of use thereof
11/25/2004WO2002086097A8 Methods for identifying the target of a compound which inhibits cellular proliferation
11/25/2004US20040237145 Control of gene expression
11/25/2004US20040236149 Microbial process for the preparation of acetic acid, as well as solvent for its extraction from the fermentation broth
11/25/2004US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004US20040236081 Immunoglobulin which binds interleukkin-1bconverting enzyme for use in diagnosis, treatment and prevention of autoimmune, neurodegenerative and cell proliferative disorders
11/25/2004US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004US20040235763 Expression vector involved in proliferation or replication, or immune protection of HSV; or transcriptional and/or translational products of target sequence
11/25/2004US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004US20040235723 Introducing ABC protein gene into yeast cell having high drug sensitivity to prepare transformed cell where protein is expressed in cell membrane, incubating cell in presence of test substance and substance which is subjected to active transfer outside cell by ABC protein in cell membrane, comparing
11/25/2004US20040235662 Probiotic composition comprising viable Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) and a formulation for maintaining viability of said Escherichia coli strain
11/25/2004US20040235140 Transgenic microorganism for use as bioreactor for expression of heterologous genes and proteins; antigen production and vaccine development
11/25/2004US20040235139 Clostridium difficile culture and toxin production methods
11/25/2004US20040235127 PUFA polyketide synthase systems and uses thereof
11/25/2004US20040235125 Novel cyclodextrin glucanotransferase (cgtase), obtained from<I> bacillus agaradherens</I> (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase
11/25/2004US20040235123 Transgenic escherichia for use as bioreactor in fermentation of alpha-lipoic acid for use in animal feeds, medicines and cosmetics
11/25/2004US20040235122 Process for the production of L-amino acids using strains of the enterobacteriaceae family
11/25/2004US20040235120 Method for producing vitamin b12
11/25/2004US20040235118 Portions of soluble recombinant botulinum toxins
11/25/2004US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004US20040235115 Comprises serine protease for use in treating and preventing heart attack, stroke, gangrene, deep venous thrombosis and peripheral arterial occlusion; fibrinolytic therapy
11/25/2004US20040235113 18 human secreted proteins
11/25/2004US20040235110 Immunoglobulin for use in identifying polypeptides which inhibit cell proliferation; immunoassay; immunodiagnostics
11/25/2004US20040235105 Sorbitol dehydrogenase, gene encoding the same and use thereof
11/25/2004US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders
11/25/2004US20040235099 Expression vector comprising glucose isomerase promoter for use as regulatory tool in multiple heterologous gene transfer and expression
11/25/2004US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004US20040235094 Regulation of human ptpase-like protein
11/25/2004US20040235093 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof
11/25/2004US20040235091 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
11/25/2004US20040235089 denaturing genetically engineered growth hormones, interferons, interleukins, immunogens or lymphokines obtained from host cells, using solutions of mercapto-organic solvents and urea, then renaturing using buffers, buffer to obtain protein in it's bioactive form
11/25/2004US20040235077 Luciferase and methods for measuring intracellular ATP using the same
11/25/2004US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004US20040235058 ULBP antibodies
11/25/2004US20040235057 Monoclonal antibody which recognizes polypeptide comprising heme binding motif and sequencially related to cytochrome p450 for use in preventing hydroxylation of retinoic acid and treating cell proliferative and skin disorders
11/25/2004US20040235038 Using single-stranded conformational polymorphisms to identify mutation which lead to cardiovascular disorders; identifying modulator for treatment of cardiac disorders
11/25/2004US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004US20040235003 Biodetectors targeted to specific ligands
11/25/2004US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004US20040234975 Expression vectors comprising nucleotide sequences coding decaprenyl diphosphate synthase for transformation and propagation in escherichia; bioreactors and heterologous gene expresssion; free radical scavanger
11/25/2004US20040234959 Truncated bard1 protein, and its diagnostic and therapeutic uses
11/25/2004US20040234550 Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella
11/25/2004US20040234545 Aids and leukemia therapy; enhancing immunology response; promote secretion of peptide such as defensin
11/25/2004US20040234538 Genetic engineered polypeptide; induce immunology response
11/25/2004US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004US20040234527 Peptides for use as translocation factors
11/25/2004US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/25/2004US20040234461 studying cell wall of oral bacterium; prevent oral diseases; anticaries agents; remove dextran from tooth surrface
11/25/2004US20040234455 Dna sequences encoding detectable cytotoxic protein generating signal; tumor imaging; gene expression
11/25/2004US20040232205 Lantibiotic
11/25/2004CA2559596A1 Antioxidant producing bacterium and uses thereof
11/25/2004CA2526935A1 Production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004CA2525870A1 Liver x receptor .alpha. splicing mutant protein, gene thereof and use thereof
11/25/2004CA2525712A1 Organism-culture apparatus and culture method
11/25/2004CA2525314A1 Method of degrading tbp using a photosynthetic bacterial strain
11/25/2004CA2523984A1 Improved transformant and process for producing polyester using the same
11/25/2004CA2522692A1 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/24/2004EP1479777A1 Method of producing astaxanthin by fermenting selected strains of xanthophyllomyces dendrorhous
11/24/2004EP1479775A1 Process for producing l-threonine with the use of bacterium beloniging to the genus escherichia